FDA approves lithium test from Diazyme Laboratories

12/17/2008 | Pharmaceutical Business Review Online

The FDA has given 510(k) clearance to Diazyme Laboratories to sell a liquid enzymatic test kit designed to measure the levels of lithium in blood specimens. The product, which offers enhanced reagent stability, shows no major interference from indigenous ions, hemoglobin and other obstructing substances.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC